More Managed Care Hits

Quote












HATERS WILL ALWAYS HATE.
QUIT THE COMPANY PLEASE.


anonymous said:
"It's a life saving drug".....half the time clinically when it works if it does at all. Nothing like selling a "let's throw it to a wall and see if it sticks" product for $39k per vial! Forget the price and forget the fact that the FDA did not require the same clinical evidence in 1952 like they would today to market something.....it barely works. Sorry hater colleagues here, that is a fact and we all know it and live it. Nothing like going into an office with your tail in between your legs to see if the doctor wants to continue therapy when it hasn't worked at all in the past 6 months.
Click to expand...
 






Haters can love this company, most of the people in it and still have deep concerns with the leadership and business model.


Wouldn’t be so quick to judge everyone as an ex employee or a short. I for one love being at MNK but I find a lot of merit in many of the criticisms of leadership and the model. I think new leadership at the top levels could be very beneficial to us all.
 












that is incredibly naive. Leadership and in particular this leadership makes the decisions that they feel their careers can handle. Which in this case is very short term. MT, HO and NM know they don’t have long ropes and are stuck in a cycle of short term thinking to dress up results 1-2 maybe 3 quarters out because that is all the BOD is going to give them if results aren’t good at this point. We’ve lost over 90% of our value. Those decisions are often to the detriment of the rest of the employees who hope to be here longer term and aren’t merely protecting their short term prospects
 
























Managed care coverage is definitely a reason for the stock drop. Analysts know that without coverage prescriptions aren't filled. Losing an entire national managed care team gives us no hope for change in the near future.
 






acthar is hard to cover. Think about it. If you are an employer and you figure out a payer is covering Acthar and banking 25-30% rebates and passing the cost on to you. Aren’t you shopping for a new insurance provider next year?!?! Insurances know covering Acthar is going to drive business away so they aren’t covering. CADs are seeing this which is why they are bolting. This whole thing is about to crash big time
 


















acthar will fall short of $1 billion this year and well short of the the $1.2 billion in 2016. I’m not a mathematician but that looks like $200 million + in lost revenue. Even more when you consider as a recently departed CAD has told our rebate percentage has far outpaced our price increases in the same time period. You don’t have to be a genius to see what is coming.
 






wasnt this same genius management team telling us we’d be close to $2 billion in 5 years when we were at the Dallas NSM? Oops.

You believe them now when they keep touting $1 billion? I don’t. I’m in one of the largest revenue producing regions of all TAs and I can tell you we are all struggling. Q2 vials were fine but not referrals. Q3 hasn’t started with a bang either. We are declining as a TA and management keeps lowering the bar so people can feel good. That’s a short term bandaids at best
 




































Top Bottom
Back
Quote